PEL2023-10-012023-12-31 PEL2023-10-012023-12-31 PEL2023-10-012023-12-31in-bse-fin:OneOtherRevenueFromOperations01Member PEL2023-10-012023-12-31in-bse-fin:FourOtherRevenueFromOperations01Member PEL2023-10-012023-12-31in-bse-fin:OneOperatingExpenses01Member PEL2023-10-012023-12-31in-bse-fin:FourOperatingExpenses01Member PEL2023-12-31 PEL2023-12-31 PEL2023-10-012023-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PEL2023-10-012023-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member PEL2023-10-012023-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PEL2023-10-012023-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss02Member PEL2023-10-012023-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member PEL2023-10-012023-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member PEL2023-10-012023-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss03Member PEL2023-10-012023-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss04Member PEL2023-10-012023-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member PEL2023-10-012023-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss02Member PEL2023-10-012023-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss03Member PEL2023-10-012023-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss04Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 500302 PEL NOTLISTED Piramal Enterprises Limited Equity 2023-04-01 2024-03-31 2024-01-29 2024-01-22 INR Crores Third quarter 2024-01-29 12:00:00 2024-01-29 15:25:00 false Not applicable Single segment Financing Activity 2023-10-01 2023-12-31 Unaudited Consolidated 19306600000.00 92500000.00 168100000.00 1545800000.00 3409000000.00 0.00 0.00 2400000.00 232100000.00 24756500000.00 705500000.00 25462000000.00 0.00 0.00 0.00 3556600000.00 11025600000.00 413800000.00 152300000.00 0.00 4526100000.00 1469100000.00 2999600000.00 24143100000.00 1318900000.00 -35398000000.00 -34079100000.00 -1501800000.00 -8073300000.00 -9575100000.00 -24504000000.00 0.00 0.00 0.00 728100000.00 -23775900000.00 221300000.00 -23554600000.00 0.00 0.00 0.00 0.00 449300000.00 2 -105.83 -105.83 0.00 0.00 -105.83 -105.83 0.02 0.00 0.00 1. The unaudited consolidated financial results have been reviewed and recommended for adoption by the Audit Committee to the Board of Directors and subsequently approved by the Board of Directors at the meeting held on 29th January, 2024. 2. The full format of the unaudited consolidated financial results for the quarter and nine months ended 31st December, 2023 are available on the Stock Exchanges websites (www.bseindia.com and www.nseindia.com) and on the Company's website viz. www.piramal.com. 3. Debt service coverage ratio & Interest service coverage ratio is not applicable to the Group. 4. In view of loss for the quarter and nine months ended 31/12/2023, equity shares which are anti-dilutive have been ignored in the calculation of diluted earnings per share. Single segment 2023-04-01 2023-12-31 Unaudited Consolidated 54130400000.00 987900000.00 485100000.00 3699300000.00 13087200000.00 0.00 0.00 51500000.00 3028400000.00 75469800000.00 1032200000.00 76502000000.00 0.00 0.00 0.00 10155000000.00 31768600000.00 1168500000.00 348500000.00 0.00 25966800000.00 -12707100000.00 11348300000.00 68048600000.00 8453400000.00 -36041400000.00 -27588000000.00 -1319000000.00 -6417300000.00 -7736300000.00 -19851700000.00 0.00 0.00 0.00 1645500000.00 -18206200000.00 -86100000.00 -18292300000.00 0.00 0.00 0.00 0.00 449300000.00 2 -78.01 -78.01 0.00 0.00 -78.01 -78.01 0.02 0.00 0.00 Other operating income 232100000.00 Other operating income 3028400000.00 Other expenses 2999600000.00 Other expenses 11348300000.00 0.00 0.00 0.00 0.00 Changes in fair values of equity instruments through OCI 52900000.00 Remeasurement of the defined benefit plans 0.00 Changes in fair values of equity instruments through OCI -3900000.00 Remeasurement of the defined benefit plans -89400000.00 52900000.00 -93300000.00 13300000.00 123800000.00 Deferred gains / (losses) on cash flow hedge 49400000.00 Changes in fair values of debt instruments through OCI 25700000.00 Exchange differences on translation of financial statements of foreign operations 182000000.00 Share of other comprehensive income/ (expense) of associates and joint ventures accounted for using the equity method -55400000.00 Deferred gains / (losses) on cash flow hedge -7900000.00 Changes in fair values of debt instruments through OCI 67300000.00 Exchange differences on translation of financial statements of foreign operations 92000000.00 Share of other comprehensive income/ (expense) of associates and joint ventures accounted for using the equity method -4400000.00 201700000.00 147000000.00 20000000.00 16000000.00 221300000.00 -86100000.00